Abstract
Sentinel lymph node status is the most important prognostic factor in primary melanoma. The number of melanoma-associated lymphatic vessels has been associated with sentinel lymph node status and survival. Vascular endothelial growth factor-C (VEGF-C) is found to promote tumour-associated lymphatic vessel growth. In many human neoplasms, VEGF-C expression in neoplastic cells or tumour-associated macrophages (TAMs) has been linked to lymphatic dissemination of tumour cells. Recent studies have suggested a correlation between VEGF-C expression in primary melanoma and the presence of lymph node metastasis. We performed VEGF-C immunohistochemical staining on melanoma tissues of 113 patients with known sentinel lymph node status. We showed that both high VEGF-C expression in melanoma cells and TAMs are positively associated with the presence of a positive sentinel lymph node. No correlation with Breslow thickness, Clark invasion level or ulceration could be detected. VEGF-C expression in melanoma cells was predictive of a shorter overall and disease-free survival, without being an independent predictor of survival. Our results confirm that VEGF-C expression in primary cutaneous melanoma plays a role in the lymphatic spread of the tumour.
| Original language | English |
|---|---|
| Pages (from-to) | 257-65 |
| Number of pages | 9 |
| Journal | Virchows Archives |
| Volume | 453 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Sept 2008 |
| Externally published | Yes |
Keywords
- Female
- Humans
- Immunohistochemistry
- Lymphatic Metastasis/pathology
- Macrophages/metabolism
- Male
- Melanoma/metabolism
- Middle Aged
- Prognosis
- Retrospective Studies
- Risk
- Sentinel Lymph Node Biopsy
- Skin Neoplasms/metabolism
- Survival Analysis
- Vascular Endothelial Growth Factor C/analysis
Fingerprint
Dive into the research topics of 'The role of VEGF-C staining in predicting regional metastasis in melanoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver